logo

Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.
[email protected]
+1234567890

Board

Dr. Dane Dickson M.D – CEO of MED-C

qodef-team-image
M.D., CEO, MED-C
Dane Dickson

Dr. Dickson graduated in 1992 from the University of Utah with a B.A. in chemistry and a minor in Mandarin Chinese. He attended medical school at the University of Utah, graduating in 1996 with honors. Subsequently, he completed an internal medicine residency at Washington University in St. Louis in 1999. He is a practicing onologist in Rexburg, Idaho.

Meet the Board of Directors

qodef-team-image
Executive Director of Friends of Cancer Research
Jeff Allen, Ph.D.

For more than five years as Executive Director of Friends, Dr. Allen has been a driving force in the growth and success of the organization. Under his leadership, Friends has evolved into a nimble, forward-thinking policy, public affairs and research think tank. He leads the development and implementation of Friends’ health and research policy portfolio, scientific initiatives, and oversees Board governance and organizational operations.

qodef-team-image
Director of Knight Cancer Institute at OHSU
Brian Druker, M.D.

Dr. Druker’s career milestones include being named a Howard Hughes Medical Investigator in 2002, becoming a member of the National Academy of Sciences in 2007, winning the Japan Award in 2011 and being elected to the American Academy of Arts and Sciences in 2012. The Minnesota native received his M.D. from the University of California at San Diego School of Medicine, completed his residency in internal medicine at Washington University in St. Louis, and served an oncology fellowship with Dana-Farber Cancer Institute at Harvard Medical School.

qodef-team-image
Former head CTO of Foundation Medicine and Clarient
Ron Collette, CISSP

Ron Collette is Chief Technology Officer of MED-C. Previously he served as Chief Information Officer for Foundation Medicine and GE Healthcare’s Clarient. He has more than 25 years of professional experience in information technologies, including work for such Fortune 500 organizations as Fluor Corporation, Pacific Life, Countrywide Mortgage and the Resolution Trust Corporation. Collette holds a B.S. in economics and an M.S. in software engineering from National University.

qodef-team-image
CEO of Center for Technology and Medical Policy and former CMO of CMS
Sean Tunis, M.D.

Dr. Tunis is the Founder, President, and Chief Executive Officer of the Center for Medical Technology Policy in Baltimore. He was a member of the Institute of Medicine Committee on Initial National Priorities for Comparative Effectiveness Research. He advises a wide range of domestic and international public and private health care organizations on issues of comparative effectiveness, evidence-based medicine, clinical research, reimbursement and health technology policy.

qodef-team-image
CEO and Founder of ADVI
Marc Samuels, J.D.

Marc Samuels is the Founder and CEO of ADVI (formerly HillCo Health). Samuels is responsible for ADVI’s strategic vision, leadership and operational execution, as well as development and execution strategies designed to grow business outside of North America. He provides senior relationship management for the firm’s top clients across life sciences, digital health, managed care and services. He is a graduate of The University of Texas School of Law, Yale School of Medicine and the University of Michigan.

qodef-team-image
Former head of CMS and FDA
Mark McClellan, M.D., Ph.D.

Dr. McClellan is director of the Duke-Margolis Center for Health Policy at Duke University. Previously, he served as a senior fellow in Economic Studies at the Brookings Institution. There he was director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership.

qodef-team-image
Managing Partner at Aeris Capital
George Rehm, J.D.

George Rehm is a managing partner of Aeris Capital in Switzerland, and has over 25 years of experience as a lawyer and executive in international licensing, technology transfer, and investment and privatization transactions in the US, Europe and Asia.